| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9975360 | The Journal of Heart and Lung Transplantation | 2005 | 4 Pages |
Abstract
The use of induction therapy either with basiliximab or rabbit anti-thymocyte serum in patients with pre-operative renal dysfunction confers renal protection early and up to 6 months post-transplant. Delayed initiation of cyclosporine might be considered to provide additional renal protection.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Diego H. MD, Santiago G. MD, Robert J. MD, Christopher MD, Vivek MD, Heather J. Ross,